etoposide has been researched along with uric acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, KM; Kessler, G; Matheke, ML | 1 |
| Culine, S; Droz, JP; Kattan, J; Kramar, A; Tavakoli-Razavi, T | 1 |
| Berger, HM; Dürken, M; Finckh, B; Fischer, R; Herrnring, C; Kohlschütter, A; Kohlschütter, B; Moison, RM; Nagel, S; Nielsen, P; Pichlmeier, U; Zander, AR | 1 |
| Blanke, CD; Hemmer, MP; Witte, RS | 1 |
| Hsia, SH; Hsueh, C; Hung, IJ; Jaing, TH; Kao, CC; Tain, YL | 1 |
| Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
1 trial(s) available for etoposide and uric acid
| Article | Year |
|---|---|
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
5 other study(ies) available for etoposide and uric acid
| Article | Year |
|---|---|
Interference of the chemotherapeutic agent etoposide with the direct phosphotungstic acid method for uric acid.
Topics: Etoposide; False Positive Reactions; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Phosphotungstic Acid; Urate Oxidase; Uric Acid | 1987 |
Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?
Topics: Acute Disease; Adolescent; Adult; Alkalies; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Calcium; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Germinoma; Humans; Kidney; L-Lactate Dehydrogenase; Middle Aged; Retrospective Studies; Risk Factors; Tumor Lysis Syndrome; Uric Acid; Vinblastine | 1994 |
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation.
Topics: Allantoin; Antineoplastic Agents; Antioxidants; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatty Acids, Unsaturated; Hematologic Neoplasms; Humans; Iron; Lipid Peroxides; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Ubiquinone; Uric Acid; Whole-Body Irradiation | 2000 |
Acute tumor lysis syndrome with choriocarcinoma.
Topics: Acidosis; Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Fatal Outcome; Heart Arrest; Humans; Hyperkalemia; Hypocalcemia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phosphates; Respiratory Insufficiency; Testicular Neoplasms; Tumor Lysis Syndrome; Uric Acid | 2000 |
Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Transfusion; Combined Modality Therapy; Disease Progression; Etoposide; Fatal Outcome; Female; Fluid Therapy; Hemofiltration; Histiocytosis, Langerhans-Cell; Humans; Infant; L-Lactate Dehydrogenase; Lymph Nodes; Mercaptopurine; Multiple Organ Failure; Neck; Orbital Diseases; Prednisolone; Sodium Bicarbonate; Temporal Bone; Tumor Lysis Syndrome; Uric Acid; Vinblastine; Vincristine | 2001 |